IMMUNOPRECISE ANTIBOD. financial statements, including revenue, expenses, profit, and loss

The total revenue of TQB for the last quarter is 3.55 M EUR, and it's 20.45% lower compared to the previous quarter. The net income of Q1 24 is -2.70 M EUR.